Equities

Encompass Health Corp

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Encompass Health Corp

Actions
  • Price (EUR)92.50
  • Today's Change0.50 / 0.54%
  • Shares traded50.00
  • 1 Year change-3.14%
  • Beta0.7104
Data delayed at least 15 minutes, as of Feb 17 2026 07:02 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2025202520242023
ASSETS
Cash And Short Term Investments728569
Total Receivables, Net619599612
Total Inventory------
Prepaid expenses184165126
Other current assets, total313835
Total current assets906887842
Property, plant & equipment, net4,3143,8473,510
Goodwill, net1,3181,2841,281
Intangibles, net308298278
Long term investments------
Note receivable - long term------
Other long term assets244219192
Total assets7,0906,5356,102
LIABILITIES
Accounts payable178171170
Accrued expenses325293274
Notes payable/short-term debt--00
Current portion long-term debt/capital leases4413925
Other current liabilities, total290239187
Total current liabilities836841656
Total long term debt2,4472,3592,688
Total debt2,4912,4982,713
Deferred income tax12710587
Minority interest838782650
Other liabilities, total404380374
Total liabilities4,6524,4684,455
SHAREHOLDERS EQUITY
Common stock--1.201.20
Additional paid-in capital--1,8471,787
Retained earnings (accumulated deficit)--797407
Treasury stock - common--(578)(547)
Unrealized gain (loss)------
Other equity, total2,438----
Total equity2,4382,0671,648
Total liabilities & shareholders' equity7,0906,5356,102
Total common shares outstanding101101100
Treasury shares - common primary issue151515
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.